Reaction

Graft Versus Host Disease In Liver reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 703 reports · 42 co-occurring drugs

As of the last recalculation, Graft Versus Host Disease In Liver appears in 703 FAERS reports alongside 42 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 225.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Thiotepa	66	225.7	227.3
Busulfan	70	146.2	146.8
Fludarabine Phosphate	141	132.6	133.0
Sirolimus	46	108.1	108.5
Posaconazole Delayed-Release	29	81.5	81.7
Cyclosporine	200	74.0	74.1
Micafungin Sodium	19	68.2	68.3
Posaconazole	35	67.1	67.2
Blinatumomab	22	64.4	64.5
Mycophenolate Mofetil	203	61.8	61.9
Mycophenolate Mofetil Hydrochloride	203	61.7	61.8
Anti-Thymocyte Globulin (Rabbit)	16	60.1	60.2
Melphalan Hydrochloride	44	55.4	55.5
Melphalan	40	55.1	55.2
Ruxolitinib	109	53.1	53.2
Tacrolimus Ointment 0.1%	167	51.8	51.8
Tacrolimus Extended-Release Capsules	167	51.6	51.7
Mycophenilic Acid	33	49.4	49.5
Tacrolimus	188	48.1	48.2
Alemtuzumab	27	42.9	43.0
Azacitidine For	25	42.2	42.2
Ganciclovir	13	38.3	38.3
Azacitidine	36	37.8	37.9
Ganciclovir Sodium	13	37.0	37.1
Mycophenolic Acid	33	32.0	32.0
Amphotericin B	13	31.3	31.3
Basiliximab	12	30.7	30.7
Imatinib	17	29.2	29.2
Cyclophosphamide Injection, Solution	140	29.0	29.0
Cyclophosphamide	140	29.0	29.0
Cyclophosphamide For Injection	140	29.0	29.0
Ursosiol	18	28.1	28.1
Voriconazole	27	27.3	27.4
Cytarabine	48	25.3	25.3
Ursodiol	18	25.1	25.1
Etoposide	57	24.9	24.9
Voriconazole Injection	17	23.7	23.7
Sorafenib	15	21.8	21.8
Meropenem	19	18.0	18.0
Axicabtagene Ciloleucel	4	12.1	12.1
Dasatinib	13	10.5	10.5
Eltrombopag Olamine	7	9.1	9.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.